A MED TECH company is supporting Blood Cancer UK with virtual fundraising event.
Becton Dickinson (BD) is a leading med tech company and partner to the global healthcare industry for more than 120 years, with its UK headquarters in Winnersh. BD supported Blood Cancer UK with its ‘Go the Distance’ challenge to help raise awareness around early diagnosis and funds for crucial research.
With the goal of beating blood cancer, BD employees took part in the virtual event.
Illustrative of their commitment to the cause, there were double the number of participants than originally planned.
The team walked, ran, cycled, swam, among other activities, the equivalent distance from Plymouth, BD’s manufacturing plant location, to Limerick, the site of its R&D hub – 1,742km (1,082 miles) across the month – with Winnersh as one of the stops. Due to impressive efforts and level of participation, the team actually collectively travelled 9,692km (6,022 miles).
Jeffrey Dern, BD Biosciences Country Leader, said: “I’m incredibly proud of the team and our achievements.
“Our strong culture of ‘doing well by doing good’ and strive to stay connected to our customers and their patients really spurred us on – come rain, wind, and little shine.
“With that attitude, we have more than quadrupled our distance, achieved our fundraising goals, and crucially, raised awareness around the importance of early detection of blood cancer.”
BD participants raised more than £5,000 for Blood Cancer UK, which will contribute to a month’s worth of funding for its Support Service, which includes a team of blood cancer support officers, social workers and clinical staff who provide information, advice, and emotional support for those suffering with the disease, as well as helping family members.
Breakthrough research is vital to advancing detection and treatment of blood cancer.
For more about the disease, common symptoms, and the work that Blood Cancer UK is doing, log on to: https://bloodcancer.org.uk/
